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Abstract Haem oxygenase-1 is upregulated by numerous
insults, including oxidative stress, and under such circumstances
it is considered to be a protective stratagem. We have measured
the haem oxygenase-1 expression in heart, lung and liver tissues
of control and iron-overloaded rats. Lung tissue from iron-
overloaded rats displayed a significant increase in the haem
oxygenase-1 protein but no changes in haem oxygenase-1
mRNA. Conversely, heart tissue showed a significant increase
in haem oxygenase-1 mRNA but no changes in haem oxygenase-
1 protein. We conclude that during oxidative stress caused by
iron overload, lung tissue responds with a rapid upregulation of
haem oxygenase-1 levels.
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1. Introduction
The lungs are particularly sensitive to oxidant damage
caused by inhaled toxins and by activated phagocytic and
in£ammatory cells within the lungs [1]. The respiratory tract
lining £uid contains several scavenging antioxidants, such as
mucin, uric acid, glutathione and ascorbate, as well as the
enzyme superoxide dismutase [2]. The protective function of
iron-binding and iron-oxidising proteins, however, in prevent-
ing lung damage is less clear, since their concentration only
greatly increases when there is lung damage and leak of plas-
ma into the lung lining £uid [3]. In order to better understand
relationships between constitutive antioxidants described
above, and inducible antioxidants produced in response to
oxidative stress, we have followed the upregulation of haem
oxygenase-1 (HO-1) in rat lung tissue after an insult with an
iron salt su⁄cient to cause iron overload.
2. Materials and methods
2.1. Animals and anaesthesia
All procedures and protocols were performed in accordance with
the Animal (Scienti¢c Procedures) Act, 1986 and approved by the
Home O⁄ce (UK) Inspectorate. Male Wistar rats (275^300 g) were
anaesthetised with pentobarbitone (60 mg/kg i.p.) and placed supine
on an electric heating pad, maintaining the body temperature at 37‡C.
A tracheotomy was performed and the animals were ventilated using
a mixture of 21% O2, 5% CO2, balanced with N2 using a volume-
cycled, small animal ventilator (Harvard Apparatus, Chatham, Kent,
UK). A cannula was inserted into the left femoral artery and attached
to a pressure transducer (Hewlett-Packard, Bracknell, UK) for con-
tinuous monitoring the mean arterial blood pressure and the with-
drawal of blood samples. A 1Fr-thermistor microprobe (Columbus
Instruments, OH, USA) was inserted into the aortic arch via the right
carotid artery. A cannula was inserted into the right atrium via the
right jugular vein and attached to a microinjector (Columbus Instru-
ments) allowing 150 Wl injection of room temperature saline. The
thermistor cardiac output was measured (Cardiotherm 500 AC-R
cardiac output computer, Columbus Instruments, OH, USA) and
the mean of two consecutive measurements within 10% of each other
were recorded. Intermittent boluses of i.p. pentobarbitone were given
to supplement anaesthesia as required.
After cannulation was completed, the continuous measurement of
mean arterial blood pressure was performed. Cardiac output measure-
ments were measured at t = 120, 150, 180, 210 and 240 min after
administration of ferric chloride or saline. At t = 120 and t = 240
min, a 0.75 ml blood sample was taken into a lithium heparin tube.
At t = 240 min, the animal was killed and the heart, lungs and liver
were harvested for RT-PCR and Western blotting.
Animals were divided at random into the following groups: Sham-
treated animals (group 1, n = 4) given 0.75 ml saline and iron-treated
animals (group 2, n = 4), given ferric chloride (0.75 ml i.v. bolus of
1 mM FeCl3, pH 3.0) applied at t = 120 min.
Initially we attempted to prepare the ferric chloride solution in pH
7.4 bu¡ered saline but this resulted in precipitation of the iron. We
therefore decided to use a non bu¡ered FeCl3 solution in our experi-
ments. Analysis of blood with a blood gas analyser (Ciba-Corning)
prior to FeCl3 treatment and at 5 min, 30 min and 1 h after FeCl3
administration showed no di¡erences in the blood pH, values which
remained unaltered at pH 7.3.
2.2. Bleomycin detectable iron
Iron chelatable to bleomycin was determined as previously de-
scribed [4]. Brie£y, the reaction mixture contained DNA, bleomycin
and the plasma sample bu¡ered to pH 7.4 with a Tris salt. In the
presence of added ascorbate, iron chelated from the plasma sample by
bleomycin degraded DNA with the release of malondialdehyde from
its deoxyribose moiety. Iron responsible for DNA degradation was
quantitated with a reference to ferric chloride standards.
2.3. Total plasma iron and iron-binding capacity
Total plasma iron and iron-binding capacity were determined using
a Sigma kit assay based on the ferrozine spectrophotometric tech-
nique. The percentage saturation of transferrin was derived from
the measured total iron-binding capacity.
2.4. Reverse transcription polymerase chain reaction (RT-PCR)
Tissues were homogenised and RNA extracted using a Tri reagent
kit (Sigma Chemical Co.). Single stranded cDNA was synthesised
from 600 ng of total RNA with the aid of Moloney Murine Leukemia
Virus Reverse Transcriptase (Life Technologies) and Oligo (dT)12ÿ18
primers (Life Technologies).
Oligo primers for PCR ampli¢cation were chosen from homologous
parts of the encoding region of the rat gene haem oxygenase-1 [5].
Double stranded cDNAs were synthesised and ampli¢ed by use of
Taq DNA polymerase (Life Technologies). Ampli¢cation was per-
formed in a DNA thermal cycler at 94, 60 and 72‡C for 30 s, 1 min
and 1 min respectively for a total of 26 cycles. Semi-quantitative
analyses were performed with reference to L-actin, which was selected
for use as a housekeeping gene. PCR fragments were analysed by gel
electrophoresis followed by ethidium bromide staining. Gels were
photographed and analysed by densitometry.
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2.5. SDS-PAGE and Western blotting analysis
Liver, lung and heart tissue samples (all n = 4) from the control
(saline-treated) and iron-treated groups were homogenised with 0.25
M sucrose/0.01 M Tris bu¡er pH 7.4 and centrifuged at 10 000Ug for
20 min. Supernatants of equal protein content were subjected to elec-
trophoresis in 14% w/v SDS-PAGE gels, with 10% w/v stacking gels.
The gels were transferred onto Hybond-C nitrocellulose membranes
(Amersham, UK). After blocking with PBS-Tween containing 5% w/v
non-fat milk, the blots were probed by a polyclonal antibody against
HO-1 and then incubated with goat anti-rabbit IgG horseradish per-
oxidase conjugate (Sigma-Aldrich, UK). After washing, the mem-
branes were treated with enhanced chemiluminescence reagent
(ECL, Amersham, UK) to reveal immunoreactive proteins. Mean re-
sults are expressed as densitometric readings, normalised to a pure
HO-1 standard run on each gel.
2.6. HO activity
To assess whether the increased formation of HO-1 protein in lung
tissue correlated with the increased enzyme activity, we measured the
total HO enzyme activity using the following technique: the HO ac-
tivity was measured in lung tissue from rats treated with the iron salt
and compared with control rats. The method of Ryter and co-workers
[6] was used, with the following modi¢cations: reactions were incu-
bated for 30 min instead of 1 h and solvent A was changed to pH 4.5
to improve the peak separation. Bilirubin peaks were found to be an
inconsistent measure of HO activity and so we measured biliverdin,
the primary product of HO activity. The HO activity was expressed as
nmol biliverdin/mg protein/h, corrected to an internal standard of
mesoporphyrin.
2.7. Data analysis
All results are expressed as mean þ S.E.M. Di¡erences between in-
dividual group means were tested using the one way, non-parametric
Mann Whitney test. P values less than 0.05 were considered signi¢-
cant.
3. Results
3.1. Cardiovascular changes
Infusion of iron into control animals induced a transient
increase in the mean arterial blood pressure (peak increase
147 þ 5.2 versus 115 þ 6.9 mm Hg at 30 min, P6 0.05) which
returned to baseline by the end of the experiment. The cardiac
output was unchanged throughout (data not shown).
3.2. Iron-overload status of rats
Rats were shown to be in a state of iron overload after
the administration of ferric chloride, by measuring bleomycin
detectable iron in the plasma. No bleomycin detectable iron
was present in rat plasma before iron administration, how-
ever, bleomycin detectable iron was present after administra-
tion (0 WM versus 19.5 þ 1.73 WM, P6 0.001). Further, the
iron saturation of transferrin was found to be 100% in iron-
overloaded rats, but only 55.0 þ 5.48% pre iron administra-
tion.
3.3. Message upregulation
HO-1 mRNA was detectable in all samples studied and
there was a signi¢cant upregulation in the hearts of rats after
iron treatment. In lung samples, however, there was no sig-
ni¢cant increase in HO-1 mRNA during iron overload (see
Fig. 1). Levels of HO-1 mRNA in the liver were also un-
changed (see Fig. 1)
HO-1 protein was detectable in all tissues examined, both
before and after iron administration. In the heart, basal levels
of HO-1 protein were elevated compared with levels in the
liver. Treatment with iron did not signi¢cantly increase
HO-1 protein levels in either tissue. However, in the lung
there was a signi¢cant (P6 0.05) increase in HO-1 protein
during iron overload (see Fig. 2).
3.4. HO enzyme activity
An increased HO activity was observed in the lungs of iron-
overloaded rats compared to controls although this was
not quite signi¢cant (292.7 þ 101.9 versus 78.2 þ 62.4 nmol
biliverdin/mg protein/h respectively, both n = 4, P = 0.056).
4. Discussion
The HO family of enzymes is responsible for the catabolic
decomposition of haemoglobin (haem) to biliverdin, carbon
monoxide and free iron. Three isomers of the enzyme have
been isolated, namely the inducible isoform HO-1, the con-
stitutive isoform HO-2 [7] and the recently discovered isoform
HO-3 [8]. HO-1 is also a stress protein, often referred to as
heat shock protein 32. Its transcription can be induced by an
array of stresses including endotoxin [9], heavy metals [10,11],
transition metal ions [12], haemoglobin and other haem pro-
teins [13,14]. Oxidative stress leads to HO-1 induction [15] and
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Fig. 1. Graphs showing haem oxygenase-1 mRNA, expressed as
densitometric ratios of HO-1 to L actin in control and iron-over-
loaded rats from lung, heart and liver, *P6 0.05.
P.B. Anning et al./FEBS Letters 447 (1999) 111^114112
under such circumstances it is considered to be protective
against oxidative damage [16]. It has been suggested that
this is due to the antioxidant properties of bilirubin [17] and
an increased ferritin synthesis [18]. There is, however, some
debate over whether HO-1 induction can solely be considered
protective, since it has recently been found that ferritin syn-
thesis occurs before HO-1 induction in the lungs of rats ex-
posed to hyperoxia or haemoglobin [19]. In addition, lungs
from HO-2 knockout mice were found to accumulate redox
active iron and to be susceptible to oxidative damage during
hyperoxia despite HO-1 induction [20]. It is more likely that
the levels of HO-1 produced and the circumstances in which it
is induced may ultimately determine whether the e¡ects of
HO-1 induction are bene¢cial or adverse. Mechanisms of cel-
lular upregulation of HO-1 by extracellularly administered
haemoglobin remains unclear since it cannot directly enter
cells. It is therefore possible that low molecular mass iron
derived from haemoglobin may provide a key signal for
HO-1 induction under such circumstances through the con-
stitutive form. Indeed, iron has been shown to induce HO-1 in
cells in culture [21,22] and in other animal models of iron
overload [23]. Furthermore, it has been shown that methae-
moglobin, but not oxyhaemoglobin, can release the hydro-
phobic iron-containing haem moiety, which is taken up by
endothelial cells in vitro, perhaps providing a mechanism by
which haemoglobin-derived iron can enter cells [24].
To support this proposal, we observed a signi¢cant upregu-
lation of HO-1 message in heart tissue of iron-overloaded rats.
In contrast, however, we found no change in HO-1 message in
the lungs. Paradoxically, a signi¢cant increase in HO-1 pro-
tein levels was observed in lung tissue of iron-overloaded rats
whereas no changes in HO-1 protein were observed in heart
tissue. Moreover, the increase in HO enzyme activity further
supported our observations that active HO-1 protein is upreg-
ulated in the lung. Failure to increase HO-1 protein levels in
heart tissue, even though mRNA levels were signi¢cantly in-
creased, most probably re£ects the delay between message
formation and protein synthesis. There were also no signi¢-
cant di¡erences in HO-1 mRNA or HO-1 protein levels in
livers of control or iron-overloaded rats, probably re£ecting
the high basal levels of HO-1 normally found in this organ.
Our results indicate that lung tissue of rats responds to oxi-
dative stress caused by iron overload with a rapid upregula-
tion of HO-1 levels. This early increase in HO-1 levels may be
of considerable importance to the lung, either as a protective
antioxidant stratagem or as a deleterious event producing
high levels of low molecular mass iron.
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